The notion that ECM1 upregulation protects against liver fibrosis is further supported by the demonstration that genetically-induced overexpression of ECM1 in hair follicle-derived mesenchymal stem cells (HF-MSCs) improved their therapeutic potential for targeting cirrhosis. Here, ECM1 is linked to Hepatic fibrosis.